Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of
clinical manifestations and a relapsing-remitting course. New data regarding pathogenic …

COVID-19 can cause acute kidney injury and may cause or exacerbate chronic kidney
diseases, including glomerular diseases. SARS-CoV-2 infection of kidney cells has been …

Objective To explore long‐term safety and tolerability of anifrolumab 300 mg compared with
placebo in patients with systemic lupus erythematosus (SLE) who completed a Treatment of …

Treatment of systemic lupus erythematosus (SLE) currently employs agents with relatively
unselective immunosuppressive properties. However, two target-specific biological drugs …

Patients with systemic lupus erythematosus (SLE) form a vulnerable group in terms of the
impact of the COVID-19 pandemic on disease management. We conducted this overview by …

Having increased popularity during the Covid-19 pandemic, vitamin D3 is currently
impressing thanks to the numerous researches aimed at its interactions with the body's …

Objective The risk of COVID‐19 infection is increased in patients with systemic lupus
erythematosus (SLE) versus those without SLE. Some immunosuppressive medications …

Abstract Purpose of Review To describe the current state of knowledge regarding COVID-19
in patients with systemic lupus erythematosus (SLE). We focus on (i) SARS-CoV-2 …

Pediatric systemic lupus erythematosus is a chronic autoimmune disorder with a highly
variable course and prognosis. It results in functional abnormalities in the immune system …

Objective To determine the association between race/ethnicity and COVID‐19 outcomes in
individuals with systemic lupus erythematosus (SLE). Methods Individuals with SLE from the …